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diseases like arthritis and, as importantly,
colon cancer, because these mice give us a
better tool for understanding how these
diseases may actually develop," he said.
Langenbach and Scott Morham, an
American Cancer Society post-doctoral fel-
low at UNC-CH, used powerful genetic
engineering techniques to eliminate, or
"knock out," the genes Ptgsl and Ptgs2
that produce the enzymes cyclooxygenase
1 (COX-1) and cyclooxygenase 2 (COX-
2), respectively, in mice. These enzymes
are the first enzymes in the prostaglandin
biosynthesis pathway.
Prostaglandins, hormone-like com-
pounds, are believed to play a role in cell
proliferation, inflammation, and many
other biological processes. Scientists had
believed that inhibition ofCOX-1 synthe-
sis by NSAIDs was the cause ofthe adverse
side effects such as occasional stomach
upset and more seriously, at higher, con-
tinual doses, ulcers and kidney damage.
Evidence for this belief was that ingested
prostaglandins protected against these
effects. Scientists also thought that
NSAIDs blocking COX-2 produced the
beneficial effects. "NSAIDs inhibit these
enzymes. When you knock out the gene, it
eliminates the enzyme and that mimics the
drugs," Morham said.
However, Langenbach discovered that
the mouse lacking COX-1 displayed no
ulceration. "Probably the most surprising
finding was that the COX-1 knock-out
mouse is really quite a healthy animal," he
said. "This animal is surviving very well
with the basal level of prostaglandins
reduced by greater than 99.5%." Given
the role prostaglandins are supposed to
play, most scientists would have thought
that these animals would not have sur-
vived. Also surprising was that when the
investigators administered one particular
NSAID, the mice were more resistant to
developing ulcers. "It might suggest that it
is the interaction ofthe enzyme itselfwith
the drug that is causing this ulcerative
problem," Morham said.
Morham's mouse lacking COX-2 also
displayed an unexpected result. This
mouse was able to mount an inflammatory
response, but was born with kidney prob-
lems. Previously, researchers believed that
COX-2 was primarily involved in the
inflammatory process, "but our data show
that both genes contribute somehow to the
process," Langenbach said. "Quite a bit of
what we see is contradicting current
dogma," Morham added.
"The results," Langenbach said, "sug-
gest that what we know about the role of
prostaglandins may have to be modified in
terms of how important they are, or that
there are other pathways and molecules in
the body that can compensate for their
lack. The therapeutic effect of aspirin-like
drugs may be on other gene products
rather than these, or in addition to these;
we really cannot say."
"Signaling by prostaglandins is very
important in almost all biological process-
es. This research should have an impact on
our understanding of how prostaglandin-
signaling molecules may be involved in
fundamental processes such as the develop-
ment ofcolon cancer," said David DeWitt,
a biochemist at Michigan State University.
To produce the mice, the investigators
used a molecular biology/biotechnology
technique developed by Oliver Smithies, a
pathologist at UNC-CH in whose labora-
tory this work was started. The investiga-
tors inactivated the gene of interest, or
"knocked it out," in cultured cells. The
modified genetic material is inserted into
mouse embryonic stem cells. This frag-
ment scans the existing genetic material,
locates a matching strand, and binds there.
Cells with the altered gene are inserted
into a developing mouse embryo and the
resulting offspring carry the defective gene.
A male and a female mouse with the defect
are mated to produce the "knock-out
mice." "These mice are highly valuable for
studying the function ofa gene in a whole
animal model," Langenbach said.
Langenbach is continuing to use the
mice to study how NSAIDs cause stomach
ulcers, and is also studying the role ofPtgs
genes in the development of various can-
cers, including colon cancer, and studying
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